Будь ласка, використовуйте цей ідентифікатор, щоб цитувати або посилатися на цей матеріал: http://ir.librarynmu.com/handle/123456789/411
Повний запис метаданих
Поле DCЗначенняМова
dc.contributor.authorHorot, I.-
dc.contributor.authorTkachenko, M.-
dc.contributor.authorRemennik, O.-
dc.date.accessioned2019-12-03T14:02:35Z-
dc.date.available2019-12-03T14:02:35Z-
dc.date.issued2017-12-
dc.identifier.issn2413-1032-
dc.identifier.urihttp://ir.librarynmu.com/handle/123456789/411-
dc.descriptionConclusions. Thus, the fractionation regime of 8 Gy 2 times a week, totaling 4 fractions, allows achieving a good local control of the primary tumor process. At the same time, the patient's state of health between fractions improves significantly; the probability of infection joining during treatment is reduced. During the study period, no radiation complications were observed in this fractionation regime.uk_UA
dc.description.abstractDespite a large number of recommendations for the installation of applicators with high-power brachytherapy, there are many controversial questions regarding the choice and placement of applicators, normalization and dose selection. Has been made an assessment the effectiveness of interstitial HDR brachytherapy under irradiation regimen of 32 Gy for 4 fractions when dosing twice a week. 46 patients with histologically confirmed non-melanoma skin cancer other localization were irradiated with MicroSelectron (radioactive source 192Ir) using interstitial HDR brachytherapy. The single focal dose was 8 Gy. The irradiation sessions were carried out 2 times a week, in total 4 fractions. The planning of the treatment process was carried out under 3D CT control. In five years of follow-up after the completion of the full course of interstitial HDR brachytherapy, 96 % of patients had complete regression of the primary tumor process and no radiation complications were observed, and 4 % had local relapses at an average of 18 months after treatment. Thus, the fractionation regime of 8 Gy 2 times a week, totaling 4 fractions, allows achieving a good local control of the primary tumor process. During the study period, no radiation complications were observed in this fractionation regime.uk_UA
dc.language.isoenuk_UA
dc.publisherThe Archive of RS Global Publishing / №12(28), December 2017 WORLD Scienceuk_UA
dc.relation.ispartofseriesWorld Science. – 2017, December. – Vol. 4, № 12 (28). – P. 9-12.;-
dc.subjectHDR brachytherapy, interstitial brachytherapy, non-melanoma skin cancer.uk_UA
dc.titleInterstitial HDR brachytherapy at non-melanoma skin canceruk_UA
dc.typeArticleuk_UA
Розташовується у зібраннях:Наукові публікації кафедри радіології та радіаційної медицини

Файли цього матеріалу:
Файл Опис РозмірФормат 
Брахитерапия - меланома.pdfHorot I.V., Tkachenko M.M., Remennik O.I. Interstitial HDR brachytherapy at non-melanoma skin cancer // World Science. – 2017, December. – Vol. 4, № 12 (28). – P. 9-12.593,74 kBAdobe PDFПереглянути/Відкрити


Усі матеріали в архіві електронних ресурсів захищені авторським правом, всі права збережені.